Back
Direxion Daily S&P Biotech Bull 3X Shares Vs. Olema Pharmaceuticals, Inc. Industry Stock Comparison
Sell
47
LABU
Direxion Daily S&P Biotech Bull 3X Shares
Last Price:
$165.23
Seasonality Move:
-4.1%
Buy
66
OLMA
Olema Pharmaceuticals, Inc.
Last Price:
$32.10
Seasonality Move:
-6.94%
Sell
47
Direxion Daily S&P Biotech Bull 3X Shares (LABU)
is a Sell
Is Direxion Daily S&P Biotech Bull 3X Shares a Buy, Sell or Hold?
-
The current Direxion Daily S&P Biotech Bull 3X Shares [LABU] share price is $160.74. The Score for LABU is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
LABU is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
66
Olema Pharmaceuticals, Inc. (OLMA)
is a Buy
Is Olema Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Olema Pharmaceuticals, Inc. [OLMA] share price is $30.68. The Score for OLMA is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
-
OLMA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
LABU Stock Price Chart
What is Direxion Daily S&P Biotech Bull 3X Shares's stock price today?
-
The Direxion Daily S&P Biotech Bull 3X Shares share price today is $160.74Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LABU is experiencing slight buying pressure.
OLMA Stock Price Chart
What is Olema Pharmaceuticals, Inc.'s stock price today?
-
The Olema Pharmaceuticals, Inc. share price today is $30.68Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and OLMA is experiencing buying pressure, which is a positive indicator for future bullish movement.
LABU Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 10.81 | Buy |
| Relative Strength Index (14 RSI): | 60.96 | Buy |
| Chaikin Money Flow: | 250229 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (127.72 - 161.4) | Buy |
| Bollinger Bands (100): | (68.13 - 133.55) | Buy |
OLMA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.69 | Buy |
| Relative Strength Index (14 RSI): | 80.55 | Buy |
| Chaikin Money Flow: | 6400058 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.73 - 28.39) | Buy |
| Bollinger Bands (100): | (3.38 - 17.56) | Buy |
LABU Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 160.06 | Buy |
| 20-day SMA: | 150.19 | Buy |
| 50-day SMA: | 129.59 | Buy |
| 200-day SMA: | 80.53 | Buy |
| 8-day EMA: | 160.13 | Buy |
| 20-day EMA: | 151.02 | Buy |
| 50-day EMA: | 129.92 | Buy |
| 200-day EMA: | 68.08 | Buy |
OLMA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 27.81 | Buy |
| 20-day SMA: | 22.38 | Buy |
| 50-day SMA: | 14.55 | Buy |
| 200-day SMA: | 7.46 | Buy |
| 8-day EMA: | 27.53 | Buy |
| 20-day EMA: | 23.23 | Buy |
| 50-day EMA: | 16.87 | Buy |
| 200-day EMA: | 9.95 | Buy |
Direxion Daily S&P Biotech Bull 3X Shares Earnings Growth & LABU Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Olema Pharmaceuticals, Inc. Earnings Growth & OLMA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.60 per share, and a decrease next year of $0.48 per share.
Direxion Daily S&P Biotech Bull 3X Shares Technical Analysis
| Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Olema Pharmaceuticals, Inc. Technical Analysis
| Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||